Elekta AB (publ) (EKTAY)

Market Cap	1.97B
Revenue (ttm)	1.86B
Net Income (ttm)	24.48M
Shares Out	n/a
EPS (ttm)	0.06
PE Ratio	80.27
Forward PE	13.13
Dividend	0.14 (2.64%)
Ex-Dividend Date	Mar 7, 2025

Volume	19
Average Volume	7,868
Open	5.16
Previous Close	5.10
Day's Range	5.04 - 5.16
52-Week Range	4.36 - 7.13
Beta	1.09
RSI	48.20
Earnings Date	Jul 4, 2025

About Elekta AB

Elekta AB (publ), a medical technology company, engages in the provision of clinical solutions for treating cancer and brain disorders worldwide. The company offers radiation therapy products, including Elekta Unity for real-time MR visualization; Elekta Versa HD, a brain metastases solution; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; and quality assurance, and treatment and motion management solutions. It also provides stereotactic radiosurgery products, suc...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1972
• Employees: 4,536
• Stock Exchange: OTCMKTS
• Ticker Symbol: EKTAY

Financial Performance

In 2025, Elekta AB's revenue was 18.02 billion, a decrease of -0.57% compared to the previous year's 18.12 billion. Earnings were 237.00 million, a decrease of -81.80%.

Financial numbers in SEK